Investigation of a fatality due to trazodone poisoning: Case report and literature review

Journal of Analytical Toxicology

Volumn 29, Issue 4, 2005, Pages 262-268

  Martínez, María A ^a   Ballesteros, Salomé ^a   Sánchez De La Torre, Carolina ^a   Almarza, Elena ^a  

^a Biology Section Apdo 863 E 41080   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; DIPYRONE; DRUG METABOLITE; MEPIVACAINE; NITROGEN; NORAMIDOPYRINE; PHOSPHORUS; PRAZEPAM; TRAZODONE;

ACCURACY; AGED; ANALYTIC METHOD; ANAMNESIS; AUTOPSY; CASE REPORT; CAUSE OF DEATH; DEPRESSION; DIODE ARRAY DETECTION; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; EMERGENCY TREATMENT; FATALITY; FORENSIC PATHOLOGY; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; ION PAIR CHROMATOGRAPHY; LINEAR SYSTEM; MALE; MASS SPECTROMETRY; REVIEW; SELF POISONING; SUICIDE; VOMITING;

EID: 20444471110     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.4.262     Document Type: Review

References (52)

1. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogo Especialidades Farmacéuticas, 2003 Plus. Einsa, Madrid, Spain, 2003, pp 1980.
2. K. Parfitt. Martindale. The Complete Drug Reference, 32nd ed, Pharmaceutical Press, London, U.K., 1999, pp 35 and pp 308-310.
3. S. Caccia, M.H. Fong, S. Garattini, and M.G. Zanini. Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone. J. Pharm. Pharmacol. 34: 605-606 (1982).
4. K. Otani, K. Mihara, N. Yasui, M. Ishida, T. Kondo, N. Tokinaga, T. Ohkubo, T. Osanai, K. Sugawara, and S. Kaneko. Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone. Prog. Neuropsychopharmacol. Biol. Psychiatry 21: 239-244 (1997).
5. K. Mihara, N. Yasui-Furukori, T. Kondo, M. Ishida, S. Ono, T. Ohkubo, T. Osanai, K. Sugawara, K. Otani, and S. Kaneko. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients. Ther. Drug. Monit. 24: 563-566 (2002).
6. M. Ishida, K. Otani, S. Kaneko, T. Ohkubo, T. Osanai, N. Yasui, K. Mihara, H. Higuchi, and K. Sugawara. Effects of various factors on steady state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine. Int. Clin. Psychopharmacol. 10:143-146(1995).
7. Drugdex® Product Index and Martindale Product Index. 1974-2004 Thomson Micromedex, Micromedex® Healthcare Series Vol. 120, exp 6/2004.
8. A.J. Bayer, M.S. Pathy, and S.I. Ankier. Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly. Br. J. Clin. Pharmacol. 16: 371-376 (1983).
9. S. Caccia, M. Ballabio, R. Samanin, M.G. Zanini, and S. Garattini. (-)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J. Pharm. Pharmacol. 33: 477-478 (1981).
10. H.J. Gijsman, J.M. Van Gerven, M.C. Tieleman, R.C. Schoemaker, M.S. Pieters, M.D. Ferrari, A.F. Cohen, and G.M. Van Kempen. Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J. Clin. Psychopharmacol. 18: 289-295 (1998).
11. J.A. Swinkels and F. de Jonghe. Safety of antidepressants. Int. Clin. Psychopharmacol. 9: 19-25 (1995).
12. M.W. Battersby, J.J. O'Mahoney, A.R. Beckwith, and J.L. Hunt. Antidepressant deaths by overdose. Aust. N. Z. J. Psychiatry 30: 223-228 (1996).
13. J.E. Spar. Plasma trazodone concentrations in elderly depressed inpatients: cardiac effects and short-term efficacy. J. Clin. Psychopharmacol. 7: 406-409 (1987).
14. D. Lefkowitz, G. Kilgo, and S. Lee. Seizures and trazodone therapy. : Arch. Gen. Psychiatry 42: 523 (1985).
15. G. Balestrieri, B. Cerudelli, S. Ciaccio, and D. Rizzoni. Hyponatraemia and seizure due to overdose of trazodone. B. M. J. 304 (6828): 686 (1992).
16. S.M. Salerno, J.S. Strong, B.J. Roth, and V. Sakata. Eosinophilic pneumonia and respiratory failure associated with a trazodone overdose. Am. J. Respir. Crit. Care Med. 152: 2170-2172 (1995).
17. R. Rao. Serotonin syndrome associated with trazodone. Int. J. Geriatr. Psychiatry 12: 129-130 (1997).
18. R. Rao. Serotonergic syndrome with trazodone. Hosp. Med. 59: 79 (1998).
19. D. Vanpee, P. Laloyaux, and J.B. Gillet. Seizure and hyponatraemia after overdose of trazadone. Am. J. Emerg. Med. 17: 430-431 (1999).
20. R.E. McCue and M. Joseph. Venlafaxine- and trazodone-induced serotonin syndrome. Am. J. Psychiatry 158: 2088-2089 (2001).
21. D.E. Adson, S. Erickson-Birkedahl, and M. Kotlyar. An unusual presentation of sertraline and trazodone overdose. Ann. Pharmacother. 35: 1375-1377 (2001).
22. M. Volz and H.M. Kellner. Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br. J. Clin. Pharmacol. 10: 299S-308S (1980).
23. E. Hassan and D.D. Miller. Toxicity and elimination of trazodone after overdose. Clin. Pharm. 4: 97-100 (1985).
24. D.E. Gamble and L.G. Peterson. Trazodone overdose: four years of experience from voluntary reports., J. Clin. Psychiatry 47: 544-546 (1986).
25. A. Martin and D.J. Pounder. Post-mortem toxico-kinetics of trazodone. Forensic Sci. Int. 56: 201-207 (1992).
26. W. Lambert, J. Van Bocxlaer, M. Piette, and A. De Leenheer. A fatal case of trazodone and dothiepin poisoning: toxicological findings. J. Anal. Toxicol. 18: 176-179 (1994).
27. K.E. Goeringer, L. Raymon, and B.K. Logan. Postmortem forensic toxicology of trazodone. J. Forensic Sci. 45: 850-856 (2000).
28. M.A. Martínez, C. Sánchez de la Torre, and E. Almarza. Simultaneous determination of viloxazine, venlafaxine, imipramine, desipramine, sertraline, and amoxapine in whole blood: comparison of two extraction/cleanup procedures for capillary gas chromatography with nitrogen-phosphorus detection. J. Anal. Toxicol. 26: 296-302 (2002).
29. M.A. Martinez, C. Sánchez de la Torre, and E. Almarza. A comparative solid-phase extraction study for the simultaneous determination of fluoxetine, amitriptyline, nortriptyline, trimipramine, maprotiline, clomipramine, and trazodone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. J. Anal. Toxicol. 27: 353-358 (2003).
30. M.A. Martinez, C. Sánchez de la Torre, and E. Almarza. A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepine, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. J. Anal. Toxicol. 28: 174-180 (2004).
31. A.S. di Tella, C. di Nunzio, P. Ricci, and G. Parisi. Determination of trazodone and its metabolite, m-CPP, in serum and urine by HPLC. J. Anal. Toxicol. 10: 233-235 (1986).
32. R.L. Miller and C.L. De Vane. Analysis of trazodone and m-chlorophenylpiperazine in plasma and brain tissue by high-performance liquid chromatography. J Chromatogr. 374: 388-393 (1986).
33. T. Ohkubo, T. Osanai, K. Sugawara, M. Ishida, K. Otani, K. Mihara, and N. Yasui. High-performance liquid Chromatographic determination of trazodone and 1-m-chlorophenylpiperazine with ultraviolet and electrochemical detector. J. Pharm. Pharmacol. 47: 340-344 (1995).
34. G.T. Vatassery, L.A. Holden, D.K. Hazel, and M.W. Dysken. Determination of trazodone and its metabolite, 1-m-chlorophenylpiperazine, in human plasma and red blood cell samples by HPLC. Clin. Biochem. 30: 149-153 (1997).
35. S.S. Jick, A.D. Dean, and H. Jick. Antidepressants and suicide. Int. Clin. Psycopharmacol. 310: 215-218 (1995).
36. J.A. Henry and C.J. Ali. Trazodone overdosage: experience from a poison information service. Hum. Toxicol. 2: 353-356 (1983).
37. D. Demorest. Death involving trazodone. J. Anal. Toxicol. 7: 63 (1983).
38. T. Lesar, R. Kingston, R. Dahms, and K. Saxena. Trazodone overdose. Ann. Emerg. Med. 12: 221-223 (1983).
39. I. Root and G.B. Ohlson. Trazodone overdose: report of two cases. J. Anal. Toxicol. 8: 91-94 (1984).
40. J.A. Henry, C.J. Ali, R. Caldwell, and R.J. Flanagan. Acute trazodone poisoning: clinical signs and plasma concentrations. Psychopathology 17: 77-81 (1984).
41. W.L. Augenstein, S.C. Smolinske, K.W. Kulig, and B.H. Rumack. Trazodone overdose and severe cardiac toxicity. Vet. Hum. Toxicol. 29: 478 (1987).
42. de Meester, G. Carbutti, L. Gabriel, and J.M. Jacques. Fatal overdose with trazodone: case report and literature review. Acta Clin. Belg. 56: 258-261 (2001).
43. The International Association of Forensic Toxicologists. Therapeutic and Toxic Drugs Concentrations List. http://www.tiaft. org/tmembers/ (Accessed March 2001).
44. S. Lippmann, S. Bunch, J. Abuton, C. Embry, M. Manshadi, and E. Surender. A trazodone overdose. Am. J. Psychiatry 139: 1373 (1982).
45. J.L. Rausch, D.M. Pavlinac, and P.E. Newman. Complete heart block following a single dose of trazodone. Am. J. Psychiatry 141: 1472-1473 (1984).
46. J.R. Pellettier and G. Bartolucci. Trazodone and cardiovascular side effects. J. Clin. Psychopharmacol. 4:119 (1984).
47. M.D. Aronson and H. Hafez. A case of trazodone-induced ventricular tachycardia. J. Clin. Psychiatry 47: 388-389 (1986).
48. B. Spivak, M. Radvan, and M. Shine. Postural hypotension with syncope possibly precipitated by trazodone. Am. J. Psychiatry 144: 1512-1513 (1987).
49. R.N. Vitullo, J.M. Wharton, N.B. Allen, and E.L. Pritchett. Trazodone-related exercise-induced nonsustained ventricular tachycardia. Chest 98: 247-248. (1990).
50. A. Mazur, B. Strasberg, J. Kusniec, and S. Sclarovsky. QT prolongation and polymorphous ventricular tachycardia associated with trazodone-amiodarone combination. Int. J. Cardiol. 52: 27-29 (1995).
51. J.L. Levenson. Prolonged QT interval after trazodone overdose. Am. J. Psychiatry 156: 969-970 (1999).
52. S. Rotzinger, J. Fang, and G.B. Baker. Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from human sources. Drug Metab. Dispos. 26: 572-575 (1998).